Insider Stock Trading History of Yachmetz Philip K


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Yachmetz Philip K since year 2005. The trader's CIK number is 1250318. At the time of this reporting, Yachmetz Philip K is the SVP - General Counse of Savient Pharmaceuticals Inc . (stock ticker symbol SVNT). See this page for all insider trading activities at Savient Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Yachmetz Philip K since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-10-15 SVNT Savient Pharmaceuticals Inc Sale 213,156 .10 20,676
2013-02-04 SVNT Savient Pharmaceuticals Inc Sale 30,500 1.02 30,957
2013-01-14 SVNT Savient Pharmaceuticals Inc Sale 1,283 1.14 1,462
2012-02-14 SVNT Savient Pharmaceuticals Inc Sale 3,540 2.02 7,150
2011-09-16 SVNT Savient Pharmaceuticals Inc Buy 7,000 4.13 28,910
2011-02-14 SVNT Savient Pharmaceuticals Inc Sale 3,210 9.88 31,724
2010-02-16 SVNT Savient Pharmaceuticals Inc Sale 5,778 13.80 79,713
2009-12-09 SVNT Savient Pharmaceuticals Inc Sale 5,418 13.31 72,118
2009-09-14 SVNT Savient Pharmaceuticals Inc Sale 3,750 15.75 59,062
2009-09-15 SVNT Savient Pharmaceuticals Inc Sale 3,750 16.25 60,937
2009-02-17 SVNT Savient Pharmaceuticals Inc Sale 5,868 5.73 33,629
2008-12-09 SVNT Savient Pharmaceuticals Inc Sale 6,400 4.86 31,104
2008-04-14 SVNT Savient Pharmaceuticals Inc Sale 3,785 19.00 71,918
2008-02-15 SVNT Savient Pharmaceuticals Inc Sale 2,361 20.00 47,231
2008-02-20 SVNT Savient Pharmaceuticals Inc Sale 2,455 20.00 49,112
2008-01-07 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.60 13,000
2008-01-08 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.42 12,100
2008-01-07 SVNT Savient Pharmaceuticals Inc Sale 5,000 23.02 115,105
2008-01-08 SVNT Savient Pharmaceuticals Inc Sale 5,000 23.15 115,755
2008-01-03 SVNT Savient Pharmaceuticals Inc Sale 5,000 24.26 121,285
2008-01-04 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.78 13,899
2008-01-02 SVNT Savient Pharmaceuticals Inc Sale 5,000 23.47 117,330
2008-01-03 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.60 13,000
2008-01-02 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.42 12,100
2008-01-04 SVNT Savient Pharmaceuticals Inc Sale 5,000 23.27 116,329
2007-12-10 SVNT Savient Pharmaceuticals Inc Sale 7,774 15.22 118,343
2007-04-12 SVNT Savient Pharmaceuticals Inc Sale 3,805 12.06 45,903
2007-03-05 SVNT Savient Pharmaceuticals Inc Sale 20,881 12.53 261,638
2007-02-15 SVNT Savient Pharmaceuticals Inc Sale 3,051 14.44 44,044
2006-04-12 SVNT Savient Pharmaceuticals Inc Sale 4,992 5.87 29,293
2005-05-18 SVNT Savient Pharmaceuticals Inc Buy 10,000 3.18 31,780

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yachmetz Philip K (SVP - General Counse of Savient Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.